Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Holding CLDX?
Track your performance easily
Celldex (CLDX) Ownership Overview
0.36% Insiders
37.39% Mutual Funds
3.20% Other Institutional Investors
11.94% ETFs
47.12% Public Companies and Individual Investors
The ownership structure of Celldex (CLDX) stock is a mix of institutional, retail, and individual investors. Approximately 52.53% of the company’s stock is owned by Institutional Investors, 0.36% is owned by Insiders, and 47.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 18, 2024 | Samuel Bates Martin Svp And Cfo | xxxxxxxxxxxxx | $608232 |
| Jun 18, 2024 | Elizabeth Crowley Sr. Vp & Cpdo | xxxxxxxxxxxxx | $1045800 |
| Jun 11, 2024 | Elizabeth Crowley Sr. Vp & Cpdo | xxxxxxxxxxxxx | $525750 |
| Jun 11, 2024 | Diane Young Svp, Chief Medical Officer | xxxxxxxxxxxxx | $1586700 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $4461333 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $28045104 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,807,708 | Institution | 5.74% | 105,206,972 | |
| 3,626,888 | Institution | 5.47% | 100,210,915 | |
| 3,367,573 | Institution | 5.08% | 93,046,042 | |
| 3,000,359 | Institution | 4.53% | 82,899,919 | |
| 2,435,122 | Institution | 3.67% | 67,282,421 | |
| 1,430,943 | Institution | 2.16% | 39,536,955 | |
| 1,378,046 | Institution | 2.08% | 38,075,411 | |
| 1,185,264 | Institution | 1.79% | 32,748,844 | |
| 1,174,390 | Institution | 1.77% | 32,448,396 | |
| 1,132,864 | Institution | 1.71% | 31,301,032 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,807,708 | Institution | 5.74% | 105,206,972 | |
| 3,367,573 | Institution | 5.08% | 93,046,042 | |
| 3,000,359 | Institution | 4.53% | 82,899,919 | |
| 1,430,943 | Institution | 2.16% | 39,536,955 | |
| 1,378,046 | Institution | 2.08% | 38,075,411 | |
| 1,185,264 | Institution | 1.79% | 32,748,844 | |
| 1,174,390 | Institution | 1.77% | 32,448,396 | |
| 1,132,864 | Institution | 1.71% | 31,301,032 | |
| 1,106,747 | Institution | 1.67% | 30,579,420 | |
| 940,914 | Institution | 1.42% | 25,997,454 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,067,162 | Institution | 3.12% | 70,262,836 | |
| 1,685,511 | Institution | 2.54% | 46,570,669 | |
| 1,002,650 | Institution | 1.51% | 34,080,074 | |
| 1,001,180 | Institution | 1.51% | 25,460,007 | |
| 470,018 | Institution | 0.71% | 12,986,597 | |
| 296,201 | Institution | 0.45% | 10,067,872 | |
| 321,156 | Institution | 0.48% | 8,166,997 | |
| 197,785 | Institution | 0.30% | 6,722,712 | |
| 113,639 | Institution | 0.17% | 3,139,846 | |
| 75,003 | Institution | 0.11% | 2,072,333 |
FAQ
Who Owns Celldex Therapeutics Inc (CLDX)?
According to the latest TipRanks data, approximately 3.20% of the company's stock is held by institutional investors, 0.36% is held by insiders, and 47.12% is held by retail investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.20% of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.12% of Celldex Therapeutics Inc (CLDX) stock is held by retail investors.
Who owns the most shares of Celldex Therapeutics Inc (CLDX)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Celldex Therapeutics Inc (CLDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.